Soft neurological signs in drug-free people with schizophrenia with and without obsessive-compulsive symptoms

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 1, 2011, Pages 68-73

  Thomas, Naveen ^a   Tharyan, Prathap ^b  

^a SUNSHINE HOSPITAL   (Australia)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MOTOR COORDINATION; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80054880717     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.23.1.68     Document Type: Article

References (37)

1. Steketee G: Disability and family burden in obsessive-compulsive disorder. Can J Psychiatry 1997; 42:919-928
2. Fenton WS, McGlasham TH: The prognostic significance of obsessive compulsive symptoms in schizophrenia. Am J Psychiatry 1986; 143:437-441
3. Insel TR, Akiskal HS: Obsessive compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry 1986; 143:1527-1533
4. Eisen JL, Beer DA, Pato MT, et al: Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry 1997; 154:271-273
5. Kruger S, Braunig P, Hoffler J, et al: Prevalence of obsessivecompulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci 2000; 12:16-24
6. Weissman MM, Bland RC, Canino GJ, et al: The cross-national epidemiology of obsessive compulsive disorder: The Cross National Collaborative Group. J Clin Psychiatry 1994; 55:5-10
7. Hwang MY, Morgan JE, Losconzcy MF: Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci 2000; 12:91-94
8. Poyurovsky M, Kurs R, Weizman A: Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder. J Clin Psychiatry 2003; 64:611
9. Lysaker PH, Marks KA, Picone JB, et al: Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis 2000; 188:78-83
10. Lysaker PH, Bryson GJ, Marks KA, et al: Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. J Neuropsychiatry Clin Neurosci 2002; 14:449-453
11. Ohta M, Kokai M, Morita Y: Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatry Clin Neurosci 2003; 57:67-74
12. Gold JM, Carpenter C, Randolph C, et al: Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997; 54:159-165
13. Saxena S, Rauch S: Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23:563-586
14. Heinrichs DW, Buchanan RW: Significance and meaning of neurological soft signs in schizophrenia. Am J Psychiatry 1988; 145:11-18
15. Bombin I, Arango C, Buchanan RW: Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull 2005; 4:962-977
16. Aoyama F, Iida J, Inoue M, et al: Brain imaging in childhood and adolescence-onset schizophrenia associated with obsessive compulsive symptoms. Acta Psychiatr Scand 2000; 102:32-37
17. Gross-Isseroff R, Hermesh H, Zohar J, et al: Neuroimaging commonality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder? World J BiolPsychiatry 2003; 4:129-134
18. Kim JJ, Youn T, Lee JM, et al: Morphometric abnormality of the insula in schizophrenia: a comparison with obsessive-compulsive disorder and normal control using MRI. Schizophr Res 2003; 60:191-198
19. Kurokawa K, Nakamura K, Sumiyoshi T, et al: Ventricular enlargement in schizophrenia spectrum patients with prodromal symptoms of obsessive-compulsive disorder. Psychiatry Res 2000; 99:83-91
20. Kwon JS, Shin YW, Kim CW, et al: Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 2003; 74:962-964
21. Zohar J: Is there room for a new diagnostic subtype: the schizo-obsessive subtype? CNS Spectr 1997; 2:49-50
22. Lysaker PH, Lancaster RS, Nees MA, et al: Patterns of obsessive-compulsive symptoms and social function in schizophrenia. Psychiatry Res 2004; 125:139-146
23. World Health Organization: The ICD-10. Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, 1993
24. Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27:335-350
25. Goodman WK, Price LH, Rasmussen SA, et al: The Yale-Brown Obsessive Compulsive Scale: development, use, and reliability Arch Gen Psychiatry 1989; 46:1006-1011
26. Kay SR, Fizbein A, Opler A: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bulletin 1987; 2:261-176
27. Guy W: Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology. Rockville, Md, US Department of Health and Human Services, 1976
28. Merriam AE, Kay SR, Opler LA, et al: Dilapidation in schizophrenia: relationship to negative syndrome and prefrontal impairment. Psychiatry Res 1990; 34:221-222
29. Gupta S, Andreasen NC, Arndt S, et al: Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 1995; 152:191-196
30. Toda M, Abi-Dargham A: Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep 2007; 9:329-336
31. Kuroki T, Nagao N, Nakahara T: Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res 2008; 172:199-212
32. Hollander E, Cohen L: Psychobiology and psychopharmacology of compulsive spectrum disorders, in Impulsivity and Compulsivity, Edited by Oldham JM, Hollander E, Skodol AE. Washington, DC, American Psychiatric Publishing, 1996, pp 143-161
33. Nurnberg H, Keith S, Paxton D: Considerations of the relevance of ethological animal models for human repetitive behavioral spectrum disorders. Biol Psychiatry 1997; 41:226-229
34. Robertson M: Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000; 123:425-462
35. McDougle C, Barr L, Goodman W, et al: Neuroleptics addition in fluvoxamine refractory obsessive-compulsive disorder. Am J Psychiatry 1990; 147:652-654
36. Swerdlow NR, Koob GF: Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-stratiopallido-thalamic function. Behav Brain Sci 1997; 10:197-245
37. Baxter L, Schwartz J, Mazziotta J, et al: Cerebral glucose metabolic rates in nondepressed patients with obsessive compulsive disorder. Am J Psychiatry 1988; 145:1560-1563.